Jump to content

Narcobarbital

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 22:45, 22 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Narcobarbital
Clinical data
ATC code
Identifiers
  • 5-(2-bromoprop-2-en-1-yl)-5-isopropyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H15BrN2O3
Molar mass303.156 g·mol−1
3D model (JSmol)
  • O=C1N(C(=O)NC(=O)C1(CC(\Br)=C)C(C)C)C
  • InChI=1S/C11H15BrN2O3/c1-6(2)11(5-7(3)12)8(15)13-10(17)14(4)9(11)16/h6H,3,5H2,1-2,4H3,(H,13,15,17) checkY
  • Key:WGMASVSHOSNKMF-UHFFFAOYSA-N checkY
  (verify)

Narcobarbital (Pronarcon) is a barbiturate derivative developed in 1932 by Carl Heinrich Friedrich Boedecker and Heinrich Gruber Schoneberg, assignors to the firm J. D. Riedel-E. de Haën AG, Berlin, Germany. Later, in 1937, may, was patented in United States.[1] It is an N-methylated derivative of propallylonal and has similar sedative effects. It is still used in veterinary medicine for inducing surgical anaesthesia.[2]


References

  1. ^ US Patent 2080071
  2. ^ N/A (1999). "Position Paper on availability of Veterinary Medicines agreed on 17 March 1999" (PDF (Public access)). Committee For Veterinary Medicinal Products: 3–8.